QUOTE AND NEWS
Canadian Business  Apr 29  Comment 
MONTREAL - Labopharm Inc. (TSX:DDS) is reviewing its assets for a potential sale or merger as part of the company's ongoing restructuring
Reuters  Apr 29  Comment 
Canadian biotechnology firm Labopharm Inc said on Friday it was looking at various options for its assets and products, as well as exploring potential business...
Canadian Business  Mar 22  Comment 
MONTREAL - Drug developer Labopharm Inc. (TSX:DDS) is eliminating 38 positions, or nearly 30 per cent of its current workforce, the Montreal-area
Canadian Business  Feb 24  Comment 
LAVAL, Que. - Montreal-area drugmaker Labopharm Inc. (TSX:DDS) reports its fourth-quarter loss grew to $7.4 million as sales and marketing
Canadian Business  Jan 3  Comment 
LAVAL, Que. - Drug developer Labopharm Inc. (TSX:DDS) says it has received more than US$5 million in royalty payments from Purdue Pharma Products
Canadian Business  Nov 11  Comment 
LAVAL, Que. - Drug developer Labopharm Inc. (TSX: DDS) has reported a net loss for its third quarter of $7.2 million, but increased revenue to
Canadian Business  Oct 14  Comment 
LAVAL, Que. - Labopharm Inc. (TSX:DDS) will receive a $10-million advance payment from Paladin Labs Inc. (TSX:PLB) under several new licensing and
Canada.com  Oct 13  Comment 
Shares in Quebec drug maker Labopharm Inc. surged as much as 13% in Wednesday trading after the company said it received approval for its twice-daily tramadol-acetaminophen product in eight European countries
Canadian Business  Aug 12  Comment 
LAVAL, Que. - Labopharm Inc. (TSX:DDS), a Quebec-based company specializing in drug-enhancement technology, has reported an increase in its net
Globe Newswire  Apr 16  Comment 
CALGARY, Alberta, April 16, 2010 (GLOBE NEWSWIRE) -- Emerging Stock Report, a leading provider of sector specific independent investment research, today initiated coverage on Labopharm Inc. (Nasdaq:DDSS). Emerging Stock Report is currently offering a





 




References

Wikinvest © 2006, 2007, 2008, 2009, 2010, 2011, 2012. Use of this site is subject to express Terms of Service, Privacy Policy, and Disclaimer. By continuing past this page, you agree to abide by these terms. Any information provided by Wikinvest, including but not limited to company data, competitors, business analysis, market share, sales revenues and other operating metrics, earnings call analysis, conference call transcripts, industry information, or price targets should not be construed as research, trading tips or recommendations, or investment advice and is provided with no warrants as to its accuracy. Stock market data, including US and International equity symbols, stock quotes, share prices, earnings ratios, and other fundamental data is provided by data partners. Stock market quotes delayed at least 15 minutes for NASDAQ, 20 mins for NYSE and AMEX. Market data by Xignite. See data providers for more details. Company names, products, services and branding cited herein may be trademarks or registered trademarks of their respective owners. The use of trademarks or service marks of another is not a representation that the other is affiliated with, sponsors, is sponsored by, endorses, or is endorsed by Wikinvest.
Powered by MediaWiki